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Epidemiological and animal studies showed that L-carnitine (LC) supplementation can ameliorate 
oxidative stress-induced tissues damage. We have previously shown that maternal cigarette smoke 
exposure (SE) can increase renal oxidative stress in newborn offspring with postnatal kidney 
underdevelopment and renal dysfunction in adulthood, which were normalised by LC administration 
in the SE dams during pregnancy. Exposure to an adverse intrauterine environment may lead to 
alteration in the epigenome, a mechanism by which adverse prenatal conditions increase the 
susceptibility to chronic disease later in life.  The current study aimed to determine whether maternal 
SE induces epigenetic changes in the offspring’s kidney are associated with renal underdevelopment, 
and the protective effect of maternal LC supplementation.  
Method: Female Balb/c mice (7 weeks) were exposed to cigarette smoke (SE) or air (Sham) for 6 
weeks prior to mating, during gestation and lactation. A subgroup of the SE dams received LC via 
drinking water (SE+LC, 1.5mmol/l) throughout gestation and lactation. Male offspring were studied 
at postnatal day (P)1, P20, and 13 weeks.  
Results: Maternal SE altered the expression of renal development markers glial-cell line-derived 
neurotrophic factor and fibroblast growth factor 2, which were associated with increased renal global 
DNA methylation and DNA methyltransferase 1 mRNA expression at birth. These disorders were 
reversed by maternal L-carnitine administration.  
Conclusion: The effect of maternal SE on renal underdevelopment involves global epigenetic 
alterations from birth, which can be prevented by maternal LC supplementation.     
 
Highlights: 
• Maternal smoking changes developmental markers 
• Maternal smoking induces renal DNA hypermethylation 
• Maternal intake of L-carnitine can normalised DNA methylation and mitigate the adverse 
impact on kidney developmental markers 
 






Epigenetics refers to mitotically heritable changes in gene expression and phenotype that are not 
mediated by alterations in the underlying DNA sequence. DNA methylation is the most studied 
epigenetic modification and describes the covalent addition of a methyl group to the 5th carbon of a 
cytosine (5-mC) residue that is located adjacent to a guanine nucleotide (CpG dinucleotide). 
Methylation of DNA can modulate gene transcription by influencing binding of proteins to DNA that 
initiates transcription. DNA hypermethylation is therefore considered an inhibitor of transcription 
while hypomethylation activates transcription. 
 
A specific epigenetic code is necessary for regulated development of the growing foetus. The 
establishment of the epigenetic program starts soon after fertilization when all DNA methylation 
marks are erased in the preimplantation embryo with subsequent resetting of the genome-wide 
methylation pattern in a cell-type specific manner in order to dictate somatic development. The theory 
of foetal programming, which links chronic disease in adulthood to adverse early life conditions, is 
increasingly recognised as an important determinant of individual’s health. The pathophysiology 
underpinning foetal programming may partly be explained by epigenetic modification. Prenatal 
smoke exposure has been associated with reduced kidney volume in the offspring 1,2.  Using an animal 
model of maternal smoking, we have previously demonstrated that maternal smoking induces renal 
underdevelopment and oxidative stress in the offspring from birth and this was associated with renal 
dysfunction at adulthood 3,4.  
 
DNA methylation is an important regulator of gene expression and increasingly recognised as a major 
mechanism of disease pathogenesis, including Chronic Kidney Disease (CKD). DNA methylation 
occurs primarily on cytosine residues in CpG dinucleotides 5 and may promote the development of 
renal disease and its comorbidities either due to environmental factors or inheritance from the mothers 
6. Epigenetic changes caused by maternal smoking during gestation have been reported in human 
foetal liver 7 and in the blood and buccal epithelial cells of newborns and adolescents 8,9, but have not 
been investigated in the kidneys. 
 
Dietary supplementation with antioxidants, has been shown to have a beneficial role in decreasing 
the effect of oxidative stress-caused damage in the lymphocyte DNA due to cigarette smoking 10. The 
amino acid supplement L-carnitine (LC) has been shown to have anti-inflammatory 11, anti-apoptotic 
12 and anti-oxidative 13 effects. In rodents, LC supplementation has been shown to improve 
atherosclerosis 14 and chronic renal failure induced by partial nephrectomy 15. In addition, LC has 




We have recently demonstrated that maternal LC supplementation during gestation and lactation 
reversed small body weight and kidney weight at birth, as well as normalising renal oxidative stress 
and renal dysfunction due to maternal SE in the male offspring 4. However, the effect of LC on 
epigenetic signatures and renal developmental markers is not known. This study therefore aimed to 
investigate the link between poor kidney development induced by maternal smoke exposure, which 
we have previously confirmed and renal epigenetic changes at various ages. We then determined 
whether the effect of maternal smoking on renal development and associated epigenetic changes in 
the offspring’s kidney can be reversed by maternal LC supplement.  
 
2. Results 
Maternal LC supplementation reversed the effect of maternal SE on the offspring development  
As shown in Table 2, SE offspring have smaller body weight than the sham offspring (P < 0.05) with 
reduced kidney mass (P < 0.05), which was not persistent until adulthood. Such growth delay was 
significantly reversed by maternal LC supplementation (P < 0.05 and P < 0.01 respectively).   
 
We have previously published that maternal SE significantly reduced glomerular development in the 
offspring at birth and this was demonstrated to be reversed by maternal LC administration during 
gestation and lactation 4. Maternal LC also reversed the changes in glomerular size and number due 
to maternal SE in the offspring 4. Here we reported the potential molecular mechanism underlying 
renal development and disorders. 
 
Effect of maternal SE and LC supplementation on renal GDNF level in the offspring 
GDNF signalling is believed to be the most critical factor for early-stage nephrogenesis during foetal 
life 24,25. Maternal SE increased renal mRNA expression of GDNF in the offspring at birth (P < 0.05, 
Figure 2A). Similarly, renal GDNF protein level was increased in SE offspring at P1 (P < 0.05), which 
was nearly doubled at P20, although without statistical significance (Figure 2B). Maternal LC 
supplementation normalised the trend at P20 (Figure 2B).   
 
Effect of maternal SE and LC supplementation on renal FGF2 level in the offspring 
Several members of the fibroblast growth factor (FGF) family can induce renal development  26. FGF2 
is a proliferating and differentiating signalling factor that promotes metanephric mesenchymal 
survival 21. Maternal smoking increases renal FGF2 mRNA and protein levels in the offspring at birth 
and weaning (P < 0.05, Figure 3A). Although maternal LC administration had no effect on FGF2 at 
P1, FGF2 mRNA and protein levels in the offspring due to maternal smoking were reversed by 





Effect of maternal SE and LC supplementation on renal Pax2 level in the offspring  
Pax2 is known to regulate mesenchyme condensation around the tips of the ureteric bud and 
metanephric mesenchymal transdifferentiation into epithelial cells 27. Maternal smoking increases 
renal Pax2 mRNA and protein levels in the offspring at birth (P < 0.05, Figure 4A). Maternal LC 
administration significantly reversed the increased renal Pax2 mRNA and protein expression in the 
offspring due to maternal SE (P < 0.05 compared to SE respectively, Figure 4A and 4B). 
 
Effect of maternal SE and LC supplementation on renal global methylation in the offspring 
The foetal environment is considered crucial in the regulation of epigenetic markers and their 
resulting influence on differentiation of cells and organs. We aimed to assess the effect of maternal 
SE on global methylation in the offspring renal tissue and this was measured at three key time points 
from birth to adulthood. Global methylation in the kidney was significantly increased at day 1 in the 
offspring of SE mothers (p<0.01 vs. Sham) and this effect was completely abrogated by maternal LC 
administration during gestation and lactation (p<0.01 vs SE, Figure 5A). The differential change in 
renal DNA methylation of SE offspring was lost by P20 (weaning age) and was not seen during 
adulthood at week 13 (Figures 5B and C). Consistently with the change of global DNA methylation 
at P1, the mRNA expression of DNA methyltransferase (Dnmt) 1 was significantly upregulated by 
maternal SE (Figure 6, P < 0.05). Dnmt3a and 3b showed similar trends of upregulation (Figure 6). 
LC administration significantly reversed the expression of Dnmt1 (P < 0.05). 
 
4. Discussion 
The main finding of this study is that maternal SE induces renal global methylation in the offspring 
at birth in association with kidney underdevelopment and upregulated renal development markers. 
Maternal LC supplementation during gestation and lactation significantly restored normal kidney 
development and epigenetic changes. This in addition to our previous report, which demonstrated the 
LC ameliorated renal injury markers and kidney function at adulthood  18, provides a proof of concept 
for the potential therapeutic role of LC to reduce the risk of renal pathology in the offspring of  
smoking mothers.  
 
We have previously reported renal underdevelopment in early life and albuminuria in adulthood in 
offspring of smoke exposed mothers in a mouse model 3. Using the same mouse model of maternal 
SE, we also demonstrated the restoration of normal kidney development and normalisation of 
albuminuria when SE dams received dietary LC supplementation during gestation and lactation 18. 




in the offspring. This study demonstrated the aberrant expression of several renal developmental 
factors in SE offspring, which was abrogated if mothers received dietary LC. There was an adaptive 
upregulation of FGF2, GDNF and Pax2 in underdeveloped kidneys from the SE offspring, each of 
which is critical for normal renal development in different stages of nephrogenesis. FGF2 for example 
promotes metanephric mesenchyme maintenance and increase in stromal cells population within the 
metanephric mesenchyme 21, the very first steps of nephrogenesis. GDNF on the other hand induce 
ureteric bud branching 23, and Pax2 is involved in nephron differentiation 22. The increased expression 
of these factors at birth may reflect a necessary adaptive response to renal underdevelopment caused 
by an adverse in utero environment, namely maternal SE in this study. Importantly, the mRNA 
expression of those development genes was normalised if LC was administered during gestation in 
the SE mothers in association with normalisation of nephrogenesis. 
 
The fact that FGF2 mRNA and protein levels as well as GDNF protein level remained significantly 
increased until weaning age (P20) supports the notion that in utero cigarette smoke exposure has long 
lasting effects on the offspring and may predispose them to foetal programming resulting in  
susceptibility to kidney disease in the long term. The upregulation of these growth factors was not 
seen in offspring of the SE+LC dams, highlighting again the potentially beneficial role of L-carnitine. 
Despite their important role in early life, if these growth factors remain elevated after renal 
development is complete, they may exert detrimental effects on renal health. FGF2 for example is 
considered as a strong mitogen for cortical renal fibroblasts and may promote autocrine fibroblast 
growth. Increased levels of FGF2 mRNA and protein expression have been shown to be  associated 
with tubulointerstitial fibrosis 28. Our results may suggest that LC mediated reduction of FGF2 at 
weaning may potentially prevent fibrogenesis in the long term. Indeed in our previous study, the renal 
expression of the inflammatory marker MCP-1 in adulthood was significantly reduced in SE offspring 
if the mothers had LC supplementation during gestation and lactation compared to those from the SE 
mothers without intervention 4. The long term anti-inflammatory effect of maternal LC 
supplementation in the kidneys of the adult offspring is consistent with a previous study 29. 
 
Although the maternal effect is still the major focus of fetal programming research, there has been 
emerging evidence regarding the paternal contribution to this process 30,31. In comparison to maternal-
fetal programming, paternal-fetal programming seems to be less potent 32. Particularly in regard to 
the effects of parental smoking on kidney development, it has been demonstrated that while maternal 
smoking during pregnancy is associated with both smaller combined kidney volume and impaired 





Although newborn babies from the smokers seem to have similar blood carnitine levels as the non-
smokers 34, the newborns do not have the capacity to biosynthesise sufficient LC for their needs. 
Supplementation in the mother allows them to  source additional LC from the breast milk to fulfil 
metabolic requirements 35. The inability of neonates to synthesize sufficient carnitine is due to 
immature hepatic gamma-butyrobetaine-hydroxlase activity. However, as pregnancy proceeds, blood 
carnitine concentration in the pregnant mother becomes lower than in the non-pregnant condition 
which may affect foetal exposure and hence levels 36. Although no study has been carried out to 
quantify optimal  LC concentrations in breast milk, it has been reported that another antioxidant 
vitamin E concentration is much lower in smokers’ breastmilk 37, while in an animal study, breast 
milk protein concentration is also somewhat lower in the mothers exposed to cigarette smoke during 
lactation 38. In humans, a previous study showed no specific effect of maternal LC supplementation 
(10 mg/kg/d) on the growth and development of premature neonates 39. However, the limitation of 
this study is that only body weight gain was used to assess growth and development, which can’t 
reflect the development of individual organs. This dose is also relatively lower than the regular dose 
of 2g/dose in healthy people 40,41.  Moreover, another animal study showed that dietary LC during 
pregnancy and lactation did not improve the growth of the offspring 42. This may be because that the 
study was carried out in normal animals without growth abnormalities. As such, when LC was used 
in the mothers who had premature neonates, it significantly improved nutrition level and metabolism 
in the infants 43. LC has also been shown to have a beneficial role in embryogenesis in mice embryos 
incubated in harsh environment, such as in the presence of pro-inflammatory tumour necrosis factor 
α and H2O2 44 .  
 
Carnitine deficiency normally correlates with nutritional inadequacies and can be observed in low-
birth weight newborns due to reasons such as maternal smoking, patients with renal tubular disorders, 
and patients with chronic renal failure undergoing haemodialysis 35,45. Our results suggest that if 
mothers continue to smoke during gestation and lactation, LC supplementation during these two 
critical developmental periods can improve renal development in offspring and ameliorate renal 
dysfunction at adulthood 18. 
 
In this study we demonstrated global hypermethylation in the SE offspring which was completely 
abrogated by maternal LC supplementation during gestation and lactation. The gene expression of 
Dnmt1 was upregulated in the kidney of P1 offspring born to smoke-exposed dams and normalised 
by LC administration. The result is consistent with the changes of global DNA methylation levels in 
these offspring, suggesting the effects of LC may be partially mediated via epigenetic modification 





Cigarette smoke is considered a powerful inducer of oxidative stress and DNA methylation 
modification 46. The effect of prenatal smoke exposure on global DNA methylation has been 
investigated in previous studies. While some studies observed global hypomethylation in cigarette 
smoke exposed individuals 47,48, the findings by Terry et al. which reported DNA hypermethylation 
in response to prenatal cigarette smoke exposure are consistent with our observations here 49. 
However, methylation profiles can be tissue and species dependent. Most studies used DNA from 
human peripheral leucocytes, cord blood or buccal cells as these are easy to obtain. To our knowledge, 
we are the first to report cigarette smoke-induced alterations in DNA methylation in offspring’s 
kidneys. We also found that the global methylation changes in the SE offspring did not last during 
the development. At weaning age, the difference in methylation between the SE offspring and Sham 
offspring were not seen. The reason for such age related epigenetic change is not clear although 
environmental factors are known to alter gene methylation 50. Nevertheless, aberrant DNA 
methylation profiles in the early period of life can potentially influence organ development and 
predispose individuals to disease susceptibility at later stages of life. Further investigations to screen 
gene specific methylation patterns are required. Indeed epigenome-wide association studies 
interrogating more than 450.000 CpG sites have become available in recent years. The largest study 
to date was a metaanalysis of 13 cohorts of smokers’ offspring whose DNA was processed with a 
Human Methylation 450k Bead Chip assay. A total of 3000 differentially methylated CpG sites 
corresponding to 2000 genes not previously related to smoking were discovered. Pathway and 
functional analysis revealed that many of the genes are involved in embyogenesis and developmental 
pathways 51. The authors discussed a number of differentially methylated genes in detail of their 
association with orofacial clefts; however we note that some of these genes such as BMP4, BMP6 
and TIMP2 also play key roles in kidney development 52-54, which were not changed in P1 offspring’s 
kidney in this study (data not shown). CpG methylation analysis of other key genes in renal 
development, such as the differentially expressed growth factors in this study, is needed in future 
studies.  
 
This study hereby demonstrated the ability of maternal LC supplementation to normalise 
hypermethylated DNA and the expression of Dnmt1 in the SE offspring. Such de-methylation 
function of LC has also been observed in a previous in vitro study using human cells 55. As L-carnitine 
reduces oxidative stress in the offspring 4, and differential DNA methylation of oxidative stress 
pathways is dominant in the maternal smoking cohort 56, L-carnitine may indirectly regulate the 
global DNA methylation level in the offspring kidney by improving antioxidant/oxidative balance. 




redox buffer system and the metabolism of methyl group, and ultimately DNA methylation changes 
during development 57. Further gene-specific investigation is required to fully justify the hypothesis. 
As LC is a readily available over-the-counter supplement with excellent safety profile, its repurposed 
application in mothers who continue to smoke during pregnancy is worthy of consideration. 
 
3. Materials and methods 
Animal model and tobacco cigarette smoke exposure protocol  
The animal experiment was approved by the Animal Care and Ethics Committee at the University of 
Technology Sydney (ACEC#2011-313A). Briefly, female Balb/c mice (7 weeks old, Animal 
Resources Centre, Perth, Australia) were housed at 20 ± 2oC and maintained on a 12:12 hour 
light/dark cycle (lights on 06:00h). After the acclimatization period, the mice were divided into Sham 
exposure group (Sham, n=12), and SE group (SE, n=24). SE was performed as previously described 
(2 cigarettes, twice daily for 6 weeks prior to mating, during gestation and lactation 3). Neither the 
male breeders nor the offspring were exposed to cigarette smoke. A subgroup of the SE dams was 
treated with LC (SE+LC, n=12) via drinking water (1.5mmol/l 17) starting at mating until pup weaning 
at postnatal day (P) 20 as previously described 4. 
 
Tissue collection 
Only male offspring were studied as we have shown that renal developmental and functional disorders 
caused by maternal smoking were only prominent in the male 3 not female offspring 19, reflected by 
changes in glomerular size and number as well as urinary albumin creatinine ratio. Male offspring 
have also been shown to be more susceptible to fetal programming of kidney disorders by maternal 
obesity 20. Male offspring were sacrificed at three different time points; postnatal (P)1 (birth), P20 
(weaning), and at week (W)13 (adulthood). Briefly, the pups were weighed and anaesthetized with 
sodium thiopental (0.1ml/g, i.p., Abbott Australasia PTY. LTD, NSW, Australia). The right kidney 
was harvested, weighed, snap frozen in liquid nitrogen and then stored in -80oC. The left kidney was 
fixed in 10% formalin (Sigma Aldrich, VIC, Australia).   
 
Real-time PCR 
Total RNA was extracted from kidney tissue using RNeasy plus mini kit (Qiagen, Valencia, CA) 
according to the manufacturer’s instructions. The single strand cDNA was synthesised using 
Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics, Mannheim, Germany). 
quantitative real-time PCR was performed using pre-optimized SYBR Green primers (Table 1, Sigma 
Aldrich, VIC, Australia) and SensiFASTTM SYBR Hi-ROX Kit (Bioline, Toronto Canada) in an 




were selected due to the previous evidence of their relevance to kidney development 21-23, and 
methylation regulation. The results were analysed by relative quantitation by RQ Manager Software 
(RQ 1.2.1, Applied Biosystems) using ∆∆Ct. The average mRNA expression of the Sham (Control) 
group was used as the calibrator and 18S rRNA was used as the housekeeping gene. 
 
Kidney immunohistochemistry (IHC) staining 
For IHC staining, 4µm kidney sections were de-waxed, dehydrated, and endogenous peroxidase was 
blocked. The sections were incubated with rabbit anti-mouse primary antibodies against proteins 
known to be associated with renal development and which we have previously demonstrated to have 
dysregulated expression in offspring of SE mothers , including glial-cell line-derived neurotrophic 
factor (GDNF, 1:100, Santa Cruz Biotechnology, CA, USA), fibroblast growth factor 2 (FGF2, 1:250, 
Santa Cruz Biotechnology, CA, USA), and paired box transcription factor (Pax2, 1:1750, Santa Cruz 
Biotechnology, CA, USA) at 4oC overnight. Negative controls were prepared by replacing the 
primary antibodies with rabbit IgG. The sections were exposed to Envision & system-HRP labelled 
polymer secondary anti-rabbit antibodies (Dako, CA, USA). On average, 6 different non-overlapping 
fields of the same kidney section were captured and 6-8 mice were used from each group. Quantitation 
of the positive signals in the images was performed using Image J software (Image J, NIH, USA).  
 
Global DNA methylation 
Genomic DNA was extracted from mouse kidneys using the DNeasy blood and tissue kit (Quiagen, 
Hilden, Germany). Offspring samples from control, smoke-exposed and smoke-exposed + L-
carnitine treated mice were used. For the detection of global methylation the MethylFlash Methylated 
DNA quantification kit (Epigentek, Farmingdale, NY, USA), a colorimetric antibody based kit was 
used that detects 5-mC, thus quantifying the relative amount of methylation in the total DNA sample.  
  
Statistical analysis 
The results are expressed as mean ± SEM. The differences between the groups were analysed using 
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Figure 2: Effect of maternal smoking and LC administration on renal mRNA and protein expression 
of GDNF in the male offspring at P1, P20 and week 13.  A) GDNF mRNA expression in the renal 
offspring from dams exposed to Sham, SE and SE+LC. B) Representative immunostaining images 
and quantitative images for GDNF proteins in the 3 groups at P1, P20 and Week 13. Results are 





Figure 3: Effect of maternal smoking and LC administration on renal FGF2 mRNA and protein 
expression in the male offspring at P1, P20 and week 13. A) FGF2 mRNA expression in the renal 
offspring from dams exposed to Sham, SE and SE+LC. B) Representative immunostaining images 
and quantitative images for FGF2 proteins in the 3 groups at P1, P20 and Week 13. Results are 





Figure 4: Effect of maternal smoking and LC administration on renal Pax2 mRNA and protein 
expression in the male offspring at P1, P20 and week 13. A) Pax2 mRNA expression in the renal 
offspring from dams exposed to Sham, SE and SE+LC. B) Representative immunostaining images 
and quantitative images for Pax2 proteins in the 3 groups at P1, P20 and Week 13. Results are 





Figure 5: Renal DNA global methylation in the offspring of smoking mother administered with LC 
or vehicle at P1 (A), P20 (B) and Week 13 (C). Results are expressed as Mean ± SEM. * P < 0.05  
 
Figure 6. RNA expression of DNA methyltransferases in the offspring kidney at P1. Results are 









Table 1: Forward and reverse sequences of the primers for rt-PCR. 
Primer Forward 5′-3′ Reveres 5′-3′ 
18S CGCGGTTCTATTTTGTTGGT AGTCGGCATCGTTTATGGTC 
GDNF ATTTTATTCAAGCCACCATTA GATACATCCACACCGTTTAGC 
FGF2 GACCCCAAGCGGCTCTACTGC GTGCCACATACCAACTGGAGT 
Pax2 CGCCGTTTCTGTGACACACAATC TGCTTGGGACCAAACACAAGGTG 
Dnmt1 GTGAACAGGAAGATGACAAC CTGGATCCTCCTTTGATTTC 
Dnmt3a ACCAGAAGAAGAGAAGAATCC CAATGATCTCCTTGACCTTAG 
Dnmt3b GACTTCATGGAAGAAGTGAC TATCATCCTGATACTCTGTGC 
 
FGF: fibroblast growth factor; GDNF: glial-cell line-derived neurotrophic factor; Pax: paired box 









Table 2: Effects of maternal SE on growth and development in male offspring. 
P1 Sham SE SE+LC 
Body weight (g) 1.63 ± 0.07 1.42 ± 0.08* 1.67 ± 0.05# 
Kidney weight (g) 0.0085 ± 0.0005 0.0067 ± 0.0004* 0.0081 ± 0.0005## 
Kidney/Body (%) 0.53 ± 0.03 0.50 ± 0.04 0.51 ± 0.03 
P20 Sham SE SE+LC 
Body weight (g) 10.0 ± 0.21 9.61 ± 0.10 10.1 ± 0.27 
Kidney weight (g) 0.066 ± 0.002 0.060 ± 0.003 0.068 ± 0.002 
Kidney/Body (%) 0.66 ± 0.02 0.63 ± 0.03 0.68 ± 0.01 
W13 Sham SE SE+LC 
Body weight (g) 25.6 ± 0.3 25.0 ± 0.4 25.7 ± 0.4 
Kidney weight (g) 0.19 ± 0.01 0.19 ± 0.01 0.20 ± 0.01 
Kidney/Body (%) 0.76 ± 0.02 0.76 ± 0.02 0.77 ± 0.02 
Results are expressed as Mean ± SEM. n=7-11. One-way ANOVA followed by 
LSD post hoc tests were used to analyze the data among three groups at the same 
age. * P < 0.05 SE vs Sham, # P < 0.05 and ## P < 0.01  SE+LC vs SE 
 
 
 
 
 
 
 
 
 
 
 
